Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yang Xiong
Institution:
Zhejiang Chinese Medical University
Observed institution:
Zhejiang Chinese Medical University
ORCID:
0009-0000-8568-180X
Observed ORCID:
0009-0000-8568-180X
OpenAlex ID:
A5125116632
A CD36-Targeting Thermosensitive Berberine Nanogel Blocks Tumor Lipid Hijacking and Potentiates Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer
2026
·
Wanyu Jin
, Shujun Xu
, et al.
·
Molecular Pharmaceutics
·
10
Synergistic potentiation of anti-PD-L1 therapy via Glut1-targeted berberine liposomes functionalized with Rg3 in triple-negative breast cancer
2026
·
Lujia Zhu
, Xiaokai Chi
, et al.
·
Journal of Drug Delivery Science and Technology
·
3
Celastrol inhibits the immune escape and proliferation of triple – negative breast cancer (TNBC) through the LKB1 – AMPK – PD-L1/MYC signaling pathway
2026
·
Mengna Shi
, Yujie Li
, et al.
·
International Immunopharmacology
·
1
BBR-RHE Co-Loaded Nanoemulsion Potentiates Anti-PD-L1 Efficacy via Lipid Metabolic Reprogramming in Triple-Negative Breast Cancer
2026
·
Jiale Wei
, Ke Qian
, et al.
·
Molecular Pharmaceutics
A berberine/rhein co-loaded liposome amplifies antitumor efficacy of doxorubicin via metabolic reprogramming
2026
·
Xin Zhang
, Ninghui Ma
, et al.
·
Chinese Herbal Medicines
Show more works
View as search
Works count:
5
Citation count:
14
H-index:
2
I10-index:
1
Year
Topic
Type